Portal de Periódicos da CAPES

When yellow jackets attack: Recurrent and severe anaphylactic reactions to insect bites and stings

2009; Wiley; Volume: 84; Issue: 12 Linguagem: Inglês

10.1002/ajh.21551

1096-8652

Daniel A. Pollyea, Tracy I. George, Christopher L. Corless, Jason Gotlib,

Drug-Induced Adverse Reactions

American Journal of HematologyVolume 84, Issue 12 p. 843-846 Solving Clinical Problems in Blood DiseasesFree Access When yellow jackets attack: Recurrent and severe anaphylactic reactions to insect bites and stings† ‡ Daniel A. Pollyea, Daniel A. Pollyea Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this authorTracy I. George, Tracy I. George Department of Pathology, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this authorChristopher Corless, Christopher Corless Department of Pathology, Oregon Health and Science University, Portland, OregonSearch for more papers by this authorJason Gotlib, Corresponding Author Jason Gotlib [email protected] Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CaliforniaStanford Cancer Center, 875 Blake Wilbur Drive, Room 2324, Stanford, CA 94305-5821Search for more papers by this author Daniel A. Pollyea, Daniel A. Pollyea Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this authorTracy I. George, Tracy I. George Department of Pathology, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this authorChristopher Corless, Christopher Corless Department of Pathology, Oregon Health and Science University, Portland, OregonSearch for more papers by this authorJason Gotlib, Corresponding Author Jason Gotlib [email protected] Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CaliforniaStanford Cancer Center, 875 Blake Wilbur Drive, Room 2324, Stanford, CA 94305-5821Search for more papers by this author First published: 28 September 2009 https://doi.org/10.1002/ajh.21551Citations: 4 † Conflict of interest: Nothing to report. ‡ A physician or group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Moffitt JE,Golden DB,Reisman RE, et al. Stinging insect hypersensitivity: A practice parameter update. J Allergy Clin Immunol 2004; 114: 869– 886. 2 Antonicelli L,Bilo MB,Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2002; 2: 341– 346. 3 Golden DB,Marsh DG,Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989; 262: 240– 244. 4 Reisman RE. Insect stings. N Engl J Med 1994; 331: 523– 527. 5 Lo Vecchio F,Tran TV. Allergic reactions from insect bites. Am J Emerg Med 2004; 22: 631. 6 Valls A,Pineda F,Belver M, et al. Anaphylactic shock caused by tick (Rhipicephalus sanguineous). J Invest Allergol Clin Immunol 2007; 17: 279– 280. 7 Brockow K,Jofer C,Behrendt H,Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226– 232. 8 Gonzalez de Olano D,de la Hoz Caballer B,Nunez Lopez R, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007; 37: 1547– 1555. 9 Valent P,Akin C,Escribano L, et al. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435– 453. 10 Horny H.-P.,Metcalfe DD,Bennett JM, et al. Mastocytosis. In: SH Swerdlow, E Campo, NL Harris, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008: 54– 63. 11 Valent P,Horny HP,Escribano L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 2001; 25: 603– 625. 12 Florian S,Krauth MT,Simonitsch-Klupp I, et al. Indolent systemic masto cytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005; 136: 273– 280. 13 Corless CL,Harrell P,Lacouture M, et al. Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn 2006; 8: 604– 612. 14 Sotlar K,Horny HP,Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004; 28: 1319– 1325. 15 Sonneck K,Florian S,Mullauer L, et al. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 2007; 142: 158– 164. 16 Akin C,Scott LM,Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 2007; 110: 2331– 2333. 17 Feger F,Ribadeau Dumas A,Leriche L, et al. Kit and c-kit mutations in mastocytosis: A short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 2002; 127: 110– 114. 18 Akin C,Fumo G,Yavuz AS, et al. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004; 103: 3222– 3225. 19 Bonadonna P,Perbellini O,Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123: 680– 686. 20 Sotlar K,Bache A,Stellmacher F, et al. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: A distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58– 66. Citing Literature Volume84, Issue12December 2009Pages 843-846 ReferencesRelatedInformation